mobile station

Uganda customers visited Fangtong

On November 5, 2025, a six-member delegation from Uganda visited Fangtong Animal Pharmaceutical Co., Ltd for an on-site business discussion. Mr. Tang Wang, Deputy General Manager and Sales Director, together with heads of relevant departments, extended a warm welcome to the visitors from Uganda.

2

During the meeting, Ms. Jiang from the Overseas Affairs Dept. gave an overview of Fangtong’s international business operations, key product lines, and production facilities that have been certified and registered in Uganda. She also introduced the company’s export and re-export trade activities. Mr. Tang Wang elaborated on Fangtong’s business philosophy, technological capabilities, product quality, and advanced manufacturing processes. The Ugandan guests commended Fangtong’s remarkable achievements, highly recognized the excellent quality, efficacy, and reputation of Fangtong products in Uganda, and expressed their desire to deepen cooperation across a broader range of products.

Following the meeting, the Ugandan delegation visited Fangtong’s water purification station, solid and sterile preparation workshops, R&D center, quality testing center, and intelligent warehousing and supply chain management facilities. The visitors listened attentively to detailed briefings on production processes, quality control systems, automation levels, and GMP compliance. They engaged in technical discussions on key parameters and manufacturing details. The delegation highly praised Fangtong’s professionalism in R&D innovation, intelligent manufacturing, comprehensive quality management, and high-standard system implementation—particularly acknowledging the company’s commitment to international standards and continuous quality improvement. The visit further strengthened mutual trust and laid a solid foundation for expanding cooperation in high value-added product lines.

5

In recent years, Fangtong has continued to enhance its R&D and smart manufacturing capabilities, while accelerating its global strategic deployment. The company has established overseas R&D centers and representative offices, continuously expanding its international service network and improving its global service responsiveness and competitiveness. Currently, Fangtong’s products are exported to many countries and regions, covering a wide range of dosage forms including large-volume injections, powders, granules, and oral solutions. With stable quality, proven efficacy, and a standardized production management system, Fangtong has earned broad recognition and an excellent reputation in international markets. Standing at a new stage of development, Fangtong will continue its dedicated efforts to advance the industry and create greater value for partners worldwide.

Send your message to us:

INQUIRY NOW
  • [cf7ic]

Post time: Nov-10-2025
WhatsApp Online Chat !